NSE › Healthcare

Vimta Labs Limited (VIMTALABS)

NSE · Healthcare · Diagnostics & Research

₹620.15+2.43%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
₹109 cr
Revenue YoY
+15.7%
Net profit
₹21 cr
Profit YoY
+15.3%
EPS
₹1.58
EPS estimate
₹1.50
Net margin
19.3%

EPS came in at 1.58 against a street estimate of 1.50 — a beat of 5.3%.

Key statistics

Market cap
₹2,783 cr
P/E
34.9
Forward P/E
0.0
P/B
5.96
Book value
₹102.28
EPS (TTM)
₹17.84
52-week high
₹899.33
52-week low
₹374.67
50-day MA
₹550.33
200-day MA
₹529.59
Beta
-0.18

Shareholding

Promoters
65.87%
Institutions
4.11%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Vimta Labs Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedZydus Lifesciences LimitedLupin LimitedMax Healthcare Institute LimitedMankind Pharma LtdLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories Limited

Data updated 2026-08-05.